未登录 分享 收藏
Outcomes of patients (pts) with unfavourable, nonsquamous cancer of unknown primary (CUP) progressing after induction chemotherapy (CTX) in the global, open-label, phase II CUPISCO study CUPISCO全球开放标签II期研究中，接受诱导化疗（CTX）后进展的预后不良、非鳞癌来源不明肿瘤（CUP）患者的结局 Bochtler, T.; Kraemer, A.; Pauli, C.; Duran-Pacheco, G.; Arslan, C.; Bigot, F.; Chalabi, N.; Cook, N.; Italiano, A.; Losa, F.; Menezes, J.; Ma, N.; Ozguroglu, M.; Pazo Cid, R. A.; Ross, J. S.; Shiu, K-K.; Arni, P.; Moch, H.; Mileshkin, L. 分享 收藏
Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study Kraemer, Alwin; Bochtler, Tilmann; Pauli, Chantal; Shiu, Kai-Keen; Cook, Natalie; de Menezes, Juliana Janoski; Pazo-Cid, Roberto A.; Losa, Ferran; Robbrecht, Debbie G. J.; Tomasek, Jiri; Arslan, Cagatay; Ozguroglu, Mustafa; Stahl, Michael; Bigot, Frederic; Kim, Sun Young; Naito, Yoichi; Italiano, Antoine; Chalabi, Nassera; Duran-Pacheco, Gonzalo; Michaud, Chantal; Scarato, Jeremy; Thomas, Marlene; Ross, Jeffrey S.; Moch, Holger; Mileshkin, Linda 分享 收藏
Circulating tumor DNA (ctDNA) to detect acquired resistance to first-line (1L) treatment of RASWT metastatic colorectal cancer (mCRC): Insights from the PLATFORM-B study 循环肿瘤DNA (ctDNA) 检测RASWT转移性结直肠癌 (mCRC) 一线 (1L) 治疗的获得性耐药: 来自platform-b研究的见解 Martelli, V.; Vidal Barrull, J.; Fernandez Rodriguez, C.; Garcia Alfonso, P.; Paez, D.; Gibert, J.; Alonso, V.; Gomez Espana, M. A.; Santos Vivas, C.; Duran Ogalla, G.; Elez Fernandez, M. E.; Garcia-Carbonero, R.; Ferreiro Monteagudo, R.; Manzano Mozo, J. L.; Losa, F.; Bellosillo Paricio, B.; Tabernero, J.; Salazar Soler, R.; Aranda Aguilar, E.; Montagut Viladot, C. 分享 收藏
The DUREC trial: Durvalumab plus total neoadjuvant therapy in locally advanced rectal cancer - a multicenter, single-arm, phase II study (GEMCAD-1703) Capdevila Castillon, J.; Alonso, V.; Macias Declara, I.; Melian, M.; Gallego Plazas, J.; Vera, R.; Riesco Martinez, M. C.; Maurel, J.; Grana Suarez, B.; Hernando, J.; Garcia Alvarez, A.; Navalpotro, B.; Soler Gonzalez, G.; Polo, E.; Garcia Fadrique, A.; Espin, E.; Fernandez Martos, C.; Villacampa Javierre, G.; Losa, F. 分享 收藏
Primary analysis of efficacy and safety in the CUPISCO trial: A randomised, global study of targeted therapy or cancer immunotherapy guided by comprehensive genomic profiling (CGP) vs platinum-based chemotherapy (CTX) in newly diagnosed, unfavourable cancer of unknown primary (CUP) Mileshkin, L.; Bochtler, T.; Pauli, C.; Duran-Pacheco, G.; Arslan, C.; Bigot, F.; Chalabi, N.; Cook, N.; Italiano, A.; Losa, F.; Menezes, J.; Michaud, C.; Ozguroglu, M.; Cid, R. A. Pazo; Ross, J. S.; Shiu, K. K.; Stahl, M.; Thomas, M.; Moch, H.; Kraemer, A. 分享 收藏
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402 Pesantez, David; ten Hoorn, Sanne; Machado, Isidro; Garcia-Albeniz, Xabier; Rodriguez-Salas, Nuria; Heredia-Soto, Victoria; Vinal, David; Pericay, Carles; Garcia-Carbonero, Rocio; Losa, Ferran; Alonso, Vicente; Vera, Ruth; Feliu Batlle, Jaime; Gallego, Javier; Salud, Antonieta; Nogue, Miquel; Layos, Laura; Montagut, Clara; Capdevila, Jaume; Vermeulen, Louis; Maurel, Joan; Fernandez-Martos, Carlos 分享 收藏
Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre network Margalef, Nuria Mulet; Castillo, Carmen; Mosteiro, Miguel; Perez, Xavier; Aguilar, Susana; Ruiz-Pace, Fiorella; Gil, Marta; Cuadra, Carmen; Ruffinelli, Jose Carlos; Martinez, Mercedes; Losa, Ferran; Soler, Gema; Teule, Alex; Castany, Roser; Gallego, Rosa; Ruiz, Andrea; Garralda, Elena; Elez, Elena; Vivancos, Ana; Tabernero, Josep; Salazar, Ramon; Dienstmann, Rodrigo; Vivas, Cristina Santos 分享 收藏
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients Toledano-Fonseca, M.; Gomez-Espana, M. A.; Elez, E.; Gravalos, C.; Garcia-Alfonso, P.; Rodriguez, R.; Losa, F.; Diaz, I. Ales; Grana, B.; Valladares-Ayerbes, M.; Garcia-Ortiz, M. V.; Polo, E.; Salgado, M.; Rivera, F.; Safont, M. J.; Salud, A.; Ruiz-Casado, A.; Tabernero, J. M.; Riesco, M. C.; Rodriguez-Ariza, A.; Aranda, E. 分享 收藏
Prediction of survival using the G8 scale frailty scale in a prospective series of elderly patients with colon cancer Soler Gonzalez, G.; Raventos, L.; M Legido-Diaz, R.; Martinez, C.; Torrent, F.; Martinez Villacampa, M.; Losa, F.; Santos Vivas, C.; Ruffinelli Rodriguez, J. C.; Teule, A.; R Gallego, M.; Manzana, A.; Rios, A.; Sanchez, S.; Piera, A.; Boixareu, C.; Salazar, R.; Saldana Canada, J. 分享 收藏
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients 循环microrna的特征预测转移性结直肠癌患者对FOLFIRI联合阿柏西普治疗的反应 Rodriguez-Ariza, A.; Espana, M. A. Gomez; Fernandez, M. E. Elez; Castro, M. C. Gravalos; Alfonso, P. Garcia; Losa, F.; Diaz, I. C. Ales; Suarez, B. Grana; Gallego, I.; Garcia-Ortiz, M. V.; Marques, E. Polo; Fernandez, M. Salgado; Herrero, F. Rivera; Aguileria, M. J. Safont; Salvia, M. A. Salud; Ruiz-Casado, A.; Tabernero, J.; Martinez, M. C. Riesco; Toledano-Fonseca, M.; Aguilar, E. Ara 分享 收藏
Cetuximab rechallenge in RAS, BRAF, EGFR-ECD wild type metastatic colorectal cancer (mCRC) patients treated with anti-EGFR therapies in first line: The CITRIC study Santos Vivas, C.; Salva, F.; Fernandez-Rodriguez, C.; Alonso Orduna, V.; Losa, F.; Paez, D.; Vidal, J.; Salud, A.; Ribera Fernandez, P.; Safont Aguilera, M.; Tarazona, N.; Hernandez-Yague, X.; Layos Romero, L.; Garcia-Carbonero, R.; Rivera, F.; Alvarez Gallego, R.; Bellosillo, B.; Montagut, C. 分享 收藏
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial Elez, Elena; Auxiliadora Gomez-Espana, Maria; Gravalos, Cristina; Garcia-Alfonso, Pilar; Jose Ortiz-Morales, Maria; Losa, Ferran; Ales Diaz, Inmaculada; Grana, Begona; Toledano-Fonseca, Marta; Valladares-Ayerbes, Manuel; Polo, Eduardo; Salgado, Mercedes; Martinez de Castro, Eva; Jose Safont, Maria; Salud, Antonieta; Ruiz-Casado, Ana; Tabernero, Josep; del Carmen Riesco, Maria; Rodriguez-Ariza, Antonio; Aranda, Enrique 分享 收藏
TA-ness classification discriminates RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts) who may benefit from antiEGFR treatment Santos, C.; Lawrence, P.; Lopez-Doriga, A.; Ragulan, C.; Fontana, E.; Desai, K.; Ps, H.; Elez Fernandez, M. E.; Aranda Aguilar, E.; Losa, F.; Paez, D.; Layos Romero, L.; Sanjuan, X.; Canas, M. A.; Azuara, D.; Queralt, B.; Fernandez-Calotti, P.; Salazar, R.; Sadanandam, A. 分享 收藏
Baseline mutational profiles of patients (pts) with carcinoma-of-unknown-primary-origin (CUP) enrolled onto CUPISCO Westphalen, C. B.; Karapetyan, A.; Beringer, A.; Bochtler, T.; Chalabi, N.; Cook, N.; Duran-Pacheco, G.; Golding, S.; Hoeglander, E.; Losa, F.; Mileshkin, L.; Moch, H.; Pauli, C.; Ross, J.; Sokol, E.; Tothill, R.; Kraemer, A. 分享 收藏
Experience in the management of PICCs (peripherally inserted central catheter) by nurses in an onco-hematologic day hospital: Activity, indications and complications Mancha, M. S.; Pages, L.; Duque, M.; Bravo, S.; Sevilla, C.; Granero, M.; Perez, A.; Valverde, M. A.; Rios, A.; Manzana, A.; Saborit, S.; Losa, F. 分享 收藏
Genomically-matched therapy in refractory CRC according to ESCAT Mulet Margalef, N.; Castillo, C.; Mosteiro, M.; Perez Martinez, J.; PAdrol, I.; Aguilar, S.; Martinez Villacampa, M.; Ruffinelli Rodriguez, J. C.; Losa, F.; Teule Vega, A.; Soler, G.; Castany, R.; Capdevila, F.; Gil-Martin, M.; Cuadra, C.; Elez, E.; Garralda, E.; Salazar, R.; Dienstmann, R.; Santos, C. 分享 收藏
Prospective evaluation of the G8 screening tool for predicting survival in elderly patients with colon cancer Soler, G.; Legido, R.; Perez, X.; Martinez-Villacampa, M.; Santos, C.; Losa, F.; Ruffinelli, J. C.; Mulet, N.; Teule, A.; Castany, R.; Gallego, R.; Carbonell, M.; Manzana, A.; Rios, A.; Saldana, J.; Salazar, R. 分享 收藏
Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy Vidal, J.; Bellosillo, B.; Santos Vivas, C.; Garcia-Alfonso, P.; Carrato, A.; Cano, M. T.; Garcia-Carbonero, R.; Elez, E.; Losa, F.; Massuti, B.; Valladares-Ayerbes, M.; Vieitez, J. M.; Manzano, J. L.; Azuara, D.; Gallego, J.; Pairet, S.; Capella, G.; Salazar, R.; Tabernero, J.; Aranda, E.; Montagut, C. 分享 收藏
Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer Santos, Cristina; Azuara, Daniel; Garcia-Carbonero, Rocio; Garcia Alfonso, Pilar; Carrato, Alfredo; Elena Elez, Ma; Gomez, Auxiliadora; Losa, Ferran; Montagut, Clara; Massuti, Bartomeu; Navarro, Valenti; Varela, Mar; Lopez-Doriga, Adriana; Moreno, Victor; Valladares, Manuel; Luis Manzano, Jose; Maria Vieitez, Jose; Aranda, Enrique; Sanjuan, Xavier; Tabernero, Josep; Capella, Gabriel; Salazar, Ramon 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏